| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.76M | 19.76M | 15.72M | 12.09M | 13.36M | 49.93M |
| Gross Profit | 14.78M | 14.78M | 11.36M | -5.16M | 9.75M | 40.27M |
| EBITDA | -824.55K | -824.55K | -3.49M | -10.55M | -14.10M | 17.15M |
| Net Income | -478.28K | -478.28K | -3.13M | -8.13M | -11.28M | 11.39M |
Balance Sheet | ||||||
| Total Assets | 27.57M | 27.57M | 26.05M | 28.98M | 38.36M | 50.72M |
| Cash, Cash Equivalents and Short-Term Investments | 10.47M | 10.47M | 9.76M | 12.16M | 24.30M | 38.24M |
| Total Debt | 4.54M | 4.54M | 3.45M | 4.00M | 4.13M | 4.38M |
| Total Liabilities | 8.41M | 8.41M | 6.95M | 7.02M | 8.60M | 9.99M |
| Stockholders Equity | 19.16M | 19.16M | 19.10M | 21.96M | 29.75M | 40.73M |
Cash Flow | ||||||
| Free Cash Flow | 1.01M | 1.01M | -1.76M | -11.97M | -13.60M | 11.73M |
| Operating Cash Flow | 1.11M | 1.11M | -1.73M | -11.96M | -13.00M | 13.46M |
| Investing Cash Flow | -1.04M | -778.38K | 2.00M | 7.06M | -628.00K | -14.18M |
| Financing Cash Flow | -533.88K | -559.87K | -637.10K | -211.49K | -357.95K | 16.19M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | AU$13.43M | -1.63 | -103.74% | ― | 14.84% | 39.64% | |
50 Neutral | AU$70.02M | -5.38 | -31.98% | ― | 34.20% | -23.90% | |
48 Neutral | $76.40M | ― | -74.00% | ― | 23.31% | -17.35% | |
44 Neutral | AU$171.94M | -16.13 | -70.55% | ― | ― | -257.32% | |
43 Neutral | AU$49.38M | ― | -2.50% | ― | 25.72% | 84.69% | |
41 Neutral | AU$60.10M | ― | -128.19% | ― | -14.25% | -22.83% |
CleanSpace Holdings Limited announced that all resolutions at their 2025 Annual General Meeting were passed by a poll, reflecting strong shareholder support. This outcome reinforces the company’s strategic direction and commitment to advancing respiratory protection technology, potentially enhancing its position in the industrial and healthcare sectors.
CleanSpace Holdings Limited presented its FY25 AGM CEO presentation, highlighting the company’s financial performance and strategic direction. The presentation emphasized the company’s commitment to maintaining strong operational performance and its focus on innovation to enhance market positioning. Stakeholders were informed about the company’s adherence to International Financial Reporting Standards and the use of non-IFRS measures to provide a clearer understanding of its financial health.
CleanSpace Holdings Limited has announced the quotation of 115,200 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code CSX. This move follows the cessation of transfer restrictions on securities previously issued under an employee incentive scheme, potentially enhancing liquidity and market presence for the company.
CleanSpace Holdings Ltd. has announced its Annual General Meeting (AGM) scheduled for November 28, 2025, where shareholders will review the 2025 Annual Report, including financial, directors’, and auditors’ reports. A key agenda item is the adoption of the Remuneration Report, which will be voted on as a non-binding advisory resolution. The meeting will also address voting exclusions for certain parties, ensuring compliance with the Corporations Act.